Navigation Links
Pharmacy Franchise Owners Association: Medicine Shoppe International and Medicap Face Claims Filed by Numerous Franchisees
Date:12/15/2011

ST. LOUIS and DES MOINES, Iowa, Dec. 15, 2011 /PRNewswire/ --  Medicine Shoppe and Medicap pharmacy owners from across the nation are filing claims against their parent companies Medicine Shoppe International (MSI) and Medicap (MC) for breach of contract for their failure to support the franchise systems.  Medicine Shoppe and Medicap are wholly-owned subsidiaries of Cardinal Health Inc., one of the nation's largest pharmaceutical distributors.

The independent pharmacy owners claim that they invested into a thriving system of branded stores, supported with a variety of agreed-upon services to be provided by MSI/Medicap. In recent years, those services have dwindled in an arbitrary decision by MSI/Medicap to stop supporting its own franchise system, while remaining steadfast in its collection of exorbitant franchise fees.

Concurrent with the reduction in services, Medicine Shoppe and Medicap have introduced an offer to new franchises whereby they may join the system for just $499 per month.  The remaining franchisees, such as those involved in the litigation, pay more than 5 percent of store sales as royalties to MSI/Medicap, a figure that reaches $25,000 per month in some cases.  

"American consumers overwhelmingly prefer independent pharmacies over "big box" retailers, yet MSI/Medicap has treated their own franchisees in such a hostile and unfair way as to make our businesses uncompetitive," says Gaye Moseman, one of the pharmacy owners filing a claim.  "For Medicine Shoppe and Medicap, by their own hands, to so damage our livelihoods and ability to fulfill the needs of our customers is morally unacceptable."

The filing of legal claims is the last step in a multi-year effort on the part of the franchisees to negotiate with MSI/Medicap and to re-align the franchise relationship to better reflect the real value of MSI/Medicap diminished support services.

"Medicine Shoppe and Medicap's failure to provide meaningful support, coupled with their exorbitant franchise fees, put the independent pharmacists in an untenable position through no fault of their own," says Robert Zarco, lead attorney representing the claimants, and member of Miami-based Zarco Einhorn Salkowski & Brito specializing in franchise, licensing and distribution law. (www.zarcolaw.com)


'/>"/>
SOURCE Pharmacy Franchise Owners Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS/pharmacy Offers Flu Vaccinations in Over 4,000 Stores
2. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
3. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
4. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
5. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
6. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
7. RICE MEMORIAL HOSPITAL PHARMACY STAFF EXPERIENCES A 55% REDUCTION IN TIME SPENT MANAGING PATIENT-SPECIFIC MEDICATIONS USING OMNICELL SINGLEPOINTE SOLUTION
8. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
9. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
10. Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
11. McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... May 15, 2017 Enterin Inc., a privately-held CNS ... developing novel compounds to treat Parkinson,s disease (PD), has enrolled ... a Phase 1/2a randomized, controlled, multicenter study involving patients with ... enroll 50 patients over a 9-to-12-month period. The first stage ... patients with PD. Participating sites include Denver ...
(Date:5/11/2017)... -- Thornhill Research Inc. ( Toronto, Ontario, Canada ... five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by the U.S. Department ... ( Ottawa, Ontario, Canada ) to ... to patients requiring emergency medical procedures in a ... have been a longtime partner with Thornhill Research ...
Breaking Medicine Technology:
(Date:5/22/2017)... ... 2017 , ... Galena, Alaska, has a population of less than 500 people. ... was targeted to build a nuclear plant by the TOSHIBA Corporation. , In “The ... Yoder describes the journey to get power to his small town, off the electrical ...
(Date:5/21/2017)... ... May 19, 2017 , ... HealthSmart, the largest ... James (Jim) Vertino as Chief Information Officer (CIO). He will be joining HealthSmart ... innovation and business performance. He defines strategic roadmaps by reimagining business processes—bridging the ...
(Date:5/21/2017)... ... May 21, 2017 , ... Florida Pain Relief Group, a division ... newest location at 109 Silver Palm Ave., Melbourne, on Monday, May 22. Initially the ... opening of the Melbourne practice, PPOA operates 23 pain management clinics in Florida and ...
(Date:5/19/2017)... ... May 19, 2017 , ... A leader in ... Charlotte recently began recruitment efforts for the inaugural cohort of its online ... knowledge and expertise to approach and address the unique nuances healthcare organizations face ...
(Date:5/19/2017)... FL (PRWEB) , ... May 19, 2017 , ... ... asset protection services and retirement planning assistance to families and business owners in ... Sclerosis Society to advocate for MS sufferers and their families. , Multiple sclerosis ...
Breaking Medicine News(10 mins):